BioROSA Technologies Inc.
Founded 2017 · $740K raised
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- biorosa.com
- Total Funding
- $740K
- Last Round
- $740K Convertible NoteNov 2022
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
BioROSA Technologies is developing biologically-based diagnostic tools for Autism Spectrum Disorder (ASD), aiming to make ASD diagnosis rapid and simple. The company's approach focuses on using biomarkers and metabolite panels (including FOCM/TS metabolites) to create a clinical standard of care for autism diagnosis. BioROSA has partnered with academic and clinical research institutions including the BRAIN Foundation and O'Sullivan Foundation, contributing to translational clinical studies published in peer-reviewed journals.
Summary
BioROSA Technologies Inc. is a Biotech company, founded in 2017. It has raised $740K in total across 2 rounds, most recently a $740K Convertible Note round in Nov 2022. Investors include SOSV and IndieBio.
Funding History
Nov 2022
Sign up to see all 2 events
Funding: Venture Round through Convertible Note. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/biorosa-technologies-inc"><img src="https://indexed.vc/api/badge/company/biorosa-technologies-inc" alt="BioROSA Technologies Inc. on Indexed.vc" width="260" height="76" /></a>